Your browser doesn't support javascript.
loading
Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
Grann, V R; Jacobson, J S; Whang, W; Hershman, D; Heitjan, D F; Antman, K H; Neugut, A I.
Affiliation
  • Grann VR; Herbert Irving Comprehensive Cancer Center, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
Cancer J Sci Am ; 6(1): 13-20, 2000.
Article in En | MEDLINE | ID: mdl-10696733
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Tamoxifen / Transcription Factors / Breast Neoplasms / Ovariectomy / Anticarcinogenic Agents / Genes, BRCA1 / Mastectomy / Mutation / Neoplasm Proteins Type of study: Clinical_trials / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Cancer J Sci Am Journal subject: NEOPLASIAS Year: 2000 Document type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Tamoxifen / Transcription Factors / Breast Neoplasms / Ovariectomy / Anticarcinogenic Agents / Genes, BRCA1 / Mastectomy / Mutation / Neoplasm Proteins Type of study: Clinical_trials / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Cancer J Sci Am Journal subject: NEOPLASIAS Year: 2000 Document type: Article Affiliation country: United States